Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1781 1
1784 1
1792 1
1794 2
1797 2
1798 1
1799 1
1800 5
1801 2
1803 2
1804 2
1805 1
1807 1
1808 2
1809 1
1810 2
1811 6
1812 6
1813 5
1814 4
1815 1
1817 3
1818 4
1819 2
1820 1
1821 5
1822 3
1823 5
1824 1
1825 4
1826 5
1827 8
1828 10
1829 10
1830 8
1831 5
1832 2
1833 3
1834 3
1836 1
1837 5
1838 5
1839 3
1840 9
1841 11
1842 14
1843 20
1844 14
1845 28
1846 21
1847 18
1848 25
1849 18
1850 15
1851 25
1852 22
1853 19
1854 19
1855 17
1856 18
1857 17
1858 19
1859 13
1860 19
1861 8
1862 14
1863 9
1864 10
1865 19
1866 20
1867 19
1868 35
1869 38
1870 44
1871 37
1872 42
1873 35
1874 36
1875 39
1876 33
1877 30
1878 33
1879 35
1880 25
1881 28
1882 37
1883 28
1884 28
1885 31
1886 17
1887 29
1888 27
1889 20
1890 39
1891 26
1892 29
1893 26
1894 15
1895 22
1896 23
1897 21
1898 22
1899 23
1900 18
1901 20
1902 20
1903 34
1904 15
1905 22
1906 16
1907 14
1908 12
1909 31
1910 37
1911 25
1912 28
1913 25
1914 35
1915 33
1916 24
1917 24
1918 27
1919 31
1920 30
1921 16
1922 22
1923 22
1924 34
1925 25
1926 21
1927 21
1928 25
1929 26
1930 24
1931 29
1932 33
1933 32
1934 34
1935 34
1936 45
1937 24
1938 16
1939 23
1940 26
1941 25
1942 30
1943 22
1944 33
1945 359
1946 1071
1947 1150
1948 1156
1949 989
1950 1261
1951 1588
1952 1623
1953 1924
1954 1893
1955 2082
1956 1855
1957 1970
1958 1916
1959 1726
1960 1684
1961 1771
1962 1949
1963 2942
1964 4107
1965 3894
1966 4016
1967 4669
1968 5657
1969 5889
1970 5872
1971 6676
1972 6955
1973 6948
1974 7193
1975 7196
1976 6812
1977 7076
1978 7232
1979 7742
1980 7491
1981 7785
1982 8370
1983 8808
1984 9615
1985 9853
1986 9982
1987 9843
1988 10226
1989 11446
1990 12048
1991 12162
1992 11983
1993 12131
1994 12320
1995 12467
1996 12485
1997 13197
1998 13258
1999 13582
2000 14500
2001 14805
2002 14799
2003 15796
2004 17543
2005 18658
2006 20249
2007 21199
2008 21847
2009 22507
2010 24112
2011 25312
2012 26522
2013 27143
2014 27891
2015 28034
2016 27836
2017 27842
2018 28577
2019 30067
2020 32769
2021 33939
2022 32773
2023 30087
2024 10647

Text availability

Article attribute

Article type

Publication date

Search Results

873,858 results

Results by year

Filters applied: . Clear all
Page 1
Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.
Raut AS, Kalonia DS. Raut AS, et al. Mol Pharm. 2016 May 2;13(5):1431-44. doi: 10.1021/acs.molpharmaceut.5b00937. Epub 2016 Apr 5. Mol Pharm. 2016. PMID: 27017836 Review.
Opalescence in protein solutions reduces aesthetic appeal of a formulation and can be an indicator of the presence of aggregates or precursor to phase separation in solution signifying reduced product stability. ...The review also highlights pharmaceutical im …
Opalescence in protein solutions reduces aesthetic appeal of a formulation and can be an indicator of the presence of aggregates or p …
Basics of Compounding with Dilutions and Concentrates.
Allen LV Jr. Allen LV Jr. Int J Pharm Compd. 2017 Jan-Feb;21(1):39-45. Int J Pharm Compd. 2017. PMID: 28346197 Review.
Pharmacists use various sources for obtaining the active pharmaceutical ingredient for compounding medications. In many cases, it is the pure drug (United States Pharmacopeia, National Formulary, or similar grade); in some cases, it can be a commercial dosage form; and, in …
Pharmacists use various sources for obtaining the active pharmaceutical ingredient for compounding medications. In many cases, it is …
The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of Relevant Applications.
Pedro SN, R Freire CS, Silvestre AJD, Freire MG. Pedro SN, et al. Int J Mol Sci. 2020 Nov 5;21(21):8298. doi: 10.3390/ijms21218298. Int J Mol Sci. 2020. PMID: 33167474 Free PMC article. Review.
Solubility, bioavailability, permeation, polymorphism, and stability concerns associated to solid-state pharmaceuticals demand for effective solutions. To overcome some of these drawbacks, ionic liquids (ILs) have been investigated as solvents, reagents, and anti-so …
Solubility, bioavailability, permeation, polymorphism, and stability concerns associated to solid-state pharmaceuticals demand for ef …
Compatibility of pentoxifylline and parenteral medications.
Campbell AL, Petrovski M, Senarathna SG, Mukadam N, Strunk T, Batty KT. Campbell AL, et al. Arch Dis Child. 2020 Apr;105(4):395-397. doi: 10.1136/archdischild-2019-317912. Epub 2019 Dec 23. Arch Dis Child. 2020. PMID: 31871042 Free article.
OBJECTIVE: To investigate the physical and chemical compatibility of pentoxifylline (PTX) with a range of parenteral medications used in neonatal intensive care. DESIGN: PTX and drug solutions were combined in glass vials, inspected for physical incompatibility and evaluat …
OBJECTIVE: To investigate the physical and chemical compatibility of pentoxifylline (PTX) with a range of parenteral medications used in neo …
Collaborative Management Strategies for Drug Shortages in Neurocritical Care.
Clark SL, Levasseur-Franklin K, Pajoumand M, Barra M, Armahizer M, Patel DV, Wyatt Chester K, Tully AP. Clark SL, et al. Neurocrit Care. 2020 Feb;32(1):226-237. doi: 10.1007/s12028-019-00730-7. Neurocrit Care. 2020. PMID: 31077080 Free PMC article. Review.
In the wake of Hurricane Maria in September 2017, hospitals across the USA had to quickly and creatively adjust medication preparation and administration techniques in light of decreased availability of intravenous (IV) bags used for compounding a vast amount of medications. Amin …
In the wake of Hurricane Maria in September 2017, hospitals across the USA had to quickly and creatively adjust medication preparation and a …
Formulation and Stability of Solutions.
Akers MJ. Akers MJ. Int J Pharm Compd. 2016 Mar-Apr;20(2):137-41. Int J Pharm Compd. 2016. PMID: 27326440
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs formulated as solution almost always have chemical and physical stability challenges as well as solubility limitations and the need to p …
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs for …
Formulation and Stability of Solutions.
Akers MJ. Akers MJ. Int J Pharm Compd. 2016 Jan-Feb;20(1):41-5. Int J Pharm Compd. 2016. PMID: 27127830
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs formulated as solution almost always have chemical and physical stability challenges as well as solubility limitations and the need to p …
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs for …
Oral dosage forms.
[No authors listed] [No authors listed] Prescrire Int. 2014 Sep;23(152):212-3. Prescrire Int. 2014. PMID: 25325122 No abstract available.
Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development.
Gukasyan HJ, Hailu S, Karami TK, Graham R. Gukasyan HJ, et al. Drug Discov Today. 2019 Aug;24(8):1587-1597. doi: 10.1016/j.drudis.2019.04.002. Epub 2019 Apr 5. Drug Discov Today. 2019. PMID: 30959112 Review.
Computational modeling and simulation (M&S) tools underpinning the elucidation of drug access routes and prediction of ocular exposure are essential for the mechanistic assessment of biopharmaceutics in the eye. Therefore, theoretical and experimental evaluation of ocu …
Computational modeling and simulation (M&S) tools underpinning the elucidation of drug access routes and prediction of ocular exposure a …
INSECTICIDE vaporizers.
[No authors listed] [No authors listed] Br Med J. 1955 May 14;1(4923):1202-3. Br Med J. 1955. PMID: 14363839 Free article. No abstract available.
873,858 results
You have reached the last available page of results. Please see the User Guide for more information.